financetom
Business
financetom
/
Business
/
Pioneer Power Shares Rise Pre-Bell Amid Narrower Q2 Loss, Higher Revenue; 2025 Revenue Outlook Reaffirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pioneer Power Shares Rise Pre-Bell Amid Narrower Q2 Loss, Higher Revenue; 2025 Revenue Outlook Reaffirmed
Aug 15, 2025 5:40 AM

08:21 AM EDT, 08/15/2025 (MT Newswires) -- Pioneer Power Solutions ( PPSI ) shares rose nearly 46% in pre-bell Friday after reporting a Q2 net loss Thursday of $0.12 per diluted share, compared with a loss of $0.21 a year earlier.

A single analyst polled by FactSet expected a loss of $0.10.

Revenue for the quarter ended June 30 was $8.4 million, up from $3.4 million a year earlier.

Two analysts polled by FactSet expected $6.9 million.

The company reaffirmed its 2025 revenue outlook of $27 million to $29 million. Two analysts polled by FactSet expect $28.6 million.

Price: 4.54, Change: +1.43, Percent Change: +45.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CareCloud Names Stephen Snyder as CO-CEO Alongside A. Hadi Chaudhry
CareCloud Names Stephen Snyder as CO-CEO Alongside A. Hadi Chaudhry
Dec 16, 2024
09:05 AM EST, 12/16/2024 (MT Newswires) -- CareCloud ( CCLD ) said Monday that Stephen Snyder will serve as co-chief executive officer alongside current CEO A. Hadi Chaudhry, effective Jan. 1. The company also named Crystal Williams as president. Chaudhry will oversee technology and artificial intelligence strategies, while Snyder will lead growth efforts, including market expansion and partnerships, CareCloud (...
Tharimmune to Initiate Phase 2 Study of TH104 for Reducing Itch in Cholangitis Patients
Tharimmune to Initiate Phase 2 Study of TH104 for Reducing Itch in Cholangitis Patients
Dec 16, 2024
09:06 AM EST, 12/16/2024 (MT Newswires) -- Tharimmune ( THAR ) said Monday it plans to initiate a phase 2 study that will evaluate TH104 in reducing itch in patients with primary biliary cholangitis, a rare, chronic liver disease. The clinical trial, expected to begin in 2025, follows results from a phase 1 study and recent regulatory feedback from the...
Sector Update: Consumer Stocks Advance Pre-Bell Monday
Sector Update: Consumer Stocks Advance Pre-Bell Monday
Dec 16, 2024
09:06 AM EST, 12/16/2024 (MT Newswires) -- Consumer shares were advancing pre-bell Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) up 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) 0.4% higher recently. Alibaba Group Holding ( BABA ) is nearing an agreement to sell its department store business Intime to Youngor Fashion...
Senti Biosciences Reports First Patient Dosed in Trial of SN301A in Hepatocellular Carcinoma
Senti Biosciences Reports First Patient Dosed in Trial of SN301A in Hepatocellular Carcinoma
Dec 16, 2024
09:05 AM EST, 12/16/2024 (MT Newswires) -- Senti Biosciences ( SNTI ) said Monday that the first patient has been dosed in the pilot trial of SN301A to treat hepatocellular carcinoma. The biotech firm said the trial, which is taking place in mainland China, is part of a collaboration with Celest Therapeutics. Senti Bio said the two companies have the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved